Literature DB >> 11011144

Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation.

A Matsumoto1, K Shikata, F Takeuchi, N Kojima, T Mizuochi.   

Abstract

The occurrence of N-linked oligosaccharides lacking galactose is significantly higher than normal in serum IgG of patients with rheumatoid arthritis (RA) in whom rheumatoid factor (RF), an autoantibody against autologous IgG, has been detected. In the present study, IgGs with and without RF activity (IgGRF and non-RF IgG, respectively) were prepared from sera of RA patients, and their oligosaccharide structures were characterized in order to investigate the relationship between RF activity and glycosylation. Three IgGRF fractions and a non-RF IgG fraction were obtained based on their ability to bind to an IgG-Sepharose column. The specific RF activity, as measured by immunoassays, was highest in the IgGRF fraction, which bound most avidly to the IgG-Sepharose. When the oligosaccharides were released by hydrazinolysis, and analyzed by MALDI-TOF mass spectrometry and HPLC, in combination with sequential exoglycosidase treatment, all the IgG samples were found to contain a series of biantennary complex-type oligosaccharides. The incidence of galactose-free oligosaccharides was significantly higher in both IgGRFs and non-RF IgG from RA patients compared with IgG from healthy individuals. In all IgGRFs, the levels of sialylation and galactosylation were lower than those in non-RF IgG from RA patients; the sialylation of non-RF IgG was the same as that of IgG from healthy individuals. In addition, the decreases in galactosylation and sialylation of oligosaccharides in IgGRF correlated well with the increase in RF activity. These findings could contribute to our understanding of the mechanisms of IgG-IgG complex formation and the pathogenicity of these complexes in RA patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011144     DOI: 10.1093/oxfordjournals.jbchem.a022794

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  37 in total

Review 1.  Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

Authors:  Björn Tackenberg; Falk Nimmerjahn; Jan D Lünemann
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

2.  N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

Authors:  William R Alley; Jacqueline A Vasseur; John A Goetz; Martin Svoboda; Benjamin F Mann; Daniela E Matei; Nancy Menning; Ahmed Hussein; Yehia Mechref; Milos V Novotny
Journal:  J Proteome Res       Date:  2012-03-07       Impact factor: 4.466

Review 3.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

4.  Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

Authors:  Falk Nimmerjahn; Robert M Anthony; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

5.  Complement C4 monitoring in the follow-up of chronic hepatitis C treatment.

Authors:  C Dumestre-Perard; D Ponard; C Drouet; V Leroy; J-P Zarski; N Dutertre; M G Colomb
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 6.  Multiple mechanisms of immune suppression by B lymphocytes.

Authors:  Matthew W Klinker; Steven K Lundy
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 7.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

8.  The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.

Authors:  Hee Jung Ryu; Fujio Takeuchi; Shoji Kuwata; Yoon Jun Kim; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

9.  Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Ramjai Wichainun; Suparaporn Wangkaew; Waraporn Sukitawut; Shoji Kuwata; Fujio Takeuchi
Journal:  Clin Rheumatol       Date:  2009-11-29       Impact factor: 2.980

10.  Application of the 50% Hydrazine Solution Method for O-Glycans Release, their Chemical Labeling, and HPLC Separation.

Authors:  D G Kisiel; I Radziejewska; A Gindzieński
Journal:  Toxicol Mech Methods       Date:  2008-06-23       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.